News Agency
The Times

Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer

  • Written by PR Newswire

SHANGHAI and WARREN, N.J., May 23, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food and Drugs Administration for the protocol of the phase III clinical trial of LAE002 (afuresertib, an AKT inhibitor) plus LAE001...

Read more: Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib)...

Mining Hose Durability and Why It Matters in Heavy-Duty Operations

A reliable mining hose is crucial for mining companies that need efficient and uninterrupted transportation of slurry, water, tailings, and abrasive materials. In demanding mining environments, equipment is exposed to constant wear, harsh operating conditions, and heavy workloads. The quality of... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion